Neuron23

Developer of an artificial intelligence-based drug discovery model designed for genetically defined neurological and immunological diseases. The company's platform leverages recent advances in human genetics, combined with their state-of-the-art artificial intelligence (AI)-enabled drug discovery and biomarker platforms, to advance therapeutics for devastating diseases, enabling patients suffering from genetic disorders with better medicines.

Kleiner Perkins

🏥 Healthcare